Cohort Study of HIV-1 Incidence Among Clients of the Thai Red Cross AIDS Research Center, Bangkok, Thailand
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to assess populations in Thailand at high risk for HIV-1 infection for potential efficacy trials of candidate HIV vaccines to include:
- assess incidence of HIV-1 and volunteer retention
- describe early viral load and CD4 counts
- assess participant willingness to participate in HIV vaccine efficacy trials and other HIV prevention trials
- describe volunteer risk behavior
| Condition |
|---|
|
HIV Infections |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
- number of HIV-1 infections per 100 person-years [ Time Frame: 5 years ] [ Designated as safety issue: No ]
- Lost to follow-up on an annual basis (10% or better) [ Time Frame: 5 years ] [ Designated as safety issue: No ]
- Post-infection viral load and CD4 count [ Time Frame: 5 years ] [ Designated as safety issue: No ]
- Willingness to participate in HIV vaccine and prevention trials [ Time Frame: 5 years ] [ Designated as safety issue: No ]
- Risk behavior by questionnaire [ Time Frame: 5 years ] [ Designated as safety issue: No ]
- HIV-1 prevalence [ Time Frame: 5 years ] [ Designated as safety issue: No ]
- HIV-1 genotype distribution [ Time Frame: 5 years ] [ Designated as safety issue: No ]
Biospecimen Retention: Samples Without DNA
Plasma, CD4, HIV-RNA
| Enrollment: | 992 |
| Study Start Date: | July 2008 |
| Study Completion Date: | June 2010 |
| Primary Completion Date: | December 2009 (Final data collection date for primary outcome measure) |
Prospective cohort study of HIV-negative participants who will receive voluntary counseling and testing (VCT) for HIV-antibody in conjunction with questionnaires on risk behavior, willingness to participate in HIV vaccine trials and other HIV prevention trials at 4 month intervals for a period of 1 year. This study will follow 1000 HIV-negative volunteers with an expected minimum of 15-20 incident HIV-infections based on a minimum incidence rate of 1.5/100 person-years. Weighted incidence estimates will be calculated with exact 95% confidence intervals.
Eligibility| Ages Eligible for Study: | 18 Years to 50 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Population in Thailand who are seeking HIV counseling and testing at TRCARC
Inclusion Criteria:
- Man or woman aged 18-50 years
- Willing to provide location or contact information and allow contact
- Thai citizenship as identified by Thai National Identification card
- Ability and willingness to provide consent
- Availability for follow-up for the planned study duration
Exclusion Criteria:
- Persons who have a history of a medical or psychiatric disorder, that in the judgment of the investigator(s), would interfere with or serve as a contraindication to adherence to the study protocol or ability to give informed consent
- Persons who are known to be HIV-positive
Contacts and Locations| Thailand | |
| The Thai Red Cross AIDS Research Centre | |
| Bangkok, Thailand, 10330 | |
| Principal Investigator: | Nittay - Phanuphak, MD. | The Thai Red Cross AIDS Research Centre, Bangkok, Thailand |
More Information
No publications provided
| Responsible Party: | The Red Cross AIDS Research Centre, Bangkok, Thailand, AFRIMS USA |
| ClinicalTrials.gov Identifier: | NCT00713531 History of Changes |
| Other Study ID Numbers: | SEARCH 008/RV233 |
| Study First Received: | July 7, 2008 |
| Last Updated: | August 10, 2010 |
| Health Authority: | Thailand: Ministry of Public Health |
Keywords provided by South East Asia Research Collaboration with Hawaii:
|
HIV-negative male and female clients ages 18-50 years seeking HIV counseling testing at TRCARC |
Additional relevant MeSH terms:
|
HIV Infections Acquired Immunodeficiency Syndrome Lentivirus Infections Retroviridae Infections RNA Virus Infections Virus Diseases |
Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Immunologic Deficiency Syndromes Immune System Diseases Slow Virus Diseases |
ClinicalTrials.gov processed this record on May 21, 2013